Proteomic analysis of the plasma from the patients with Parkinson’s disease

Proteomic analysis of the plasma from the patients with Parkinson’s disease

碩士 === 輔仁大學 === 生命科學系碩士班 === 93 === Proteomics is a new knowledge of biological total proteome research. Within the proteomic technologies, the combination of Two-dimensional electrophoresis（2-DE） and mass spectrometry（MS）is the most popular skill.Using this method makes scientists able to separate...

Full description

Bibliographic Details
Main Authors:	Ching-Yu, Lin, 林今昱
Other Authors:	陳翰民
Format:	Others
Language:	zh-TW
Published:	2004
Online Access:	http://ndltd.ncl.edu.tw/handle/61043936779448586879

Similar Items

Explorations of plasma biomarkers for Parkinson's disease by proteomic approaches
by: LIN,CHING-YU, et al.
Published: (2010)

Integrated Metabolomics and Proteomics Analysis Reveals Plasma Lipid Metabolic Disturbance in Patients With Parkinson’s Disease
by: Ling Hu, et al.
Published: (2020-06-01)

Using proteomic approaches to identify the differential expressed proteins in the plasma of patients with Parkinson’s Disease
by: Chiang, Chia-ying, et al.
Published: (2009)

Proteome analysis of human substantia nigra in Parkinson's disease
by: Werner Cornelius J, et al.
Published: (2008-02-01)

Urinary proteome profiling for stratifying patients with familial Parkinson’s disease
by: Sebastian Virreira Winter, et al.
Published: (2021-03-01)

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
by: Chin-Hsien Lin, et al.
Published: (2018-04-01)

Plasma Proteomic Analysis in Morquio A Disease
by: José V. Álvarez, et al.
Published: (2021-06-01)

Comparative analysis of plasma proteome in nasopharyngeal carcinoma patients
by: Yu-Chin Chen, et al.
Published: (2006)

Proteomic Analysis of the Cerebrospinal Fluid of Parkinson's Disease Patients Pre- and Post-Deep Brain Stimulation
by: Er-Song Wang, et al.
Published: (2013-05-01)

Biomonitoring of Mycotoxins in Plasma of Patients with Alzheimer’s and Parkinson’s Disease
by: Beatriz Arce-López, et al.
Published: (2021-07-01)

Proteomic Profile of Saliva in Parkinson’s Disease Patients: A Proof of Concept Study
by: Monika Figura, et al.
Published: (2021-05-01)

Integrated glycomics and proteomics in aging, Parkinson's disease and cancer
by: Raghunathan, Rekha
Published: (2019)

Two-dimensional gel electrophoresis of plasma proteome from infant patients of biliary atresia
by: Meng-Yi Lin, et al.
Published: (2005)

Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson’s Disease
by: Kyu Hwan Shim, et al.
Published: (2021-05-01)

Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
by: Faith L. Anderson, et al.
Published: (2021-01-01)

Plasma Prolidase Activity and Oxidative Stress in Patients with Parkinson’s Disease
by: Akhilesh Kumar Verma, et al.
Published: (2015-01-01)

Immunological Markers in Plasma and CSF distinguish Vascular Parkinsonism from Idiopathic Parkinson's Disease
by: Vrecko Karoline, et al.
Published: (2008-02-01)

Uncaria rhynchophylla Ameliorates Parkinson’s Disease by Inhibiting HSP90 Expression: Insights from Quantitative Proteomics
by: Yu-Long Lan, et al.
Published: (2018-06-01)

Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.
by: Marijan Posavi, et al.
Published: (2019-10-01)

Blood Plasma of Patients with Parkinson’s Disease Increases Alpha-Synuclein Aggregation and Neurotoxicity
by: Peng Wang, et al.
Published: (2016-01-01)

Plasma proteome in multiple sclerosis disease progression
by: Arjan Malekzadeh, et al.
Published: (2019-09-01)

Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis
by: Irene Zubiri, et al.
Published: (2018-11-01)

Proteomic Analysis of Plasma-Derived Extracellular Vesicles in Smokers and Patients with Chronic Obstructive Pulmonary Disease
by: Isaac K. Sundar, et al.
Published: (2019-06-01)

Corrigendum: Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson's Disease
by: Kyu Hwan Shim, et al.
Published: (2021-07-01)

Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson’s Disease
by: Chen-Chih Chung, et al.
Published: (2021-05-01)

Assessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson's disease.
by: Hai-Wen Zhao, et al.
Published: (2013-01-01)

Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease
by: Vasiliki Lygirou, et al.
Published: (2018-04-01)

Analysis of Microelectrode Recording for Parkinson’s Disease based on Multi-Feature
by: Yu Wen Tseng, et al.
Published: (2014)

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson's disease
by: Karayel, O., et al.
Published: (2022)

Optimization of quantitative proteomic analysis of clots generated from plasma of patients with venous thromboembolism
by: Aneta Stachowicz, et al.
Published: (2017-11-01)

Potential two‐step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study
by: Sid E. O'Bryant, et al.
Published: (2019-12-01)

Proteomic Analysis of the Effect of Korean Red Ginseng in the Striatum of a Parkinson's Disease Mouse Model.
by: Dongsoo Kim, et al.
Published: (2016-01-01)

Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: Implications for Parkinson disease
by: Victor S. Van Laar, et al.
Published: (2008-03-01)

Transcriptome and proteome profiling of neural stem cells from the human subventricular zone in Parkinson’s disease
by: Vanessa Donega, et al.
Published: (2019-06-01)

Gait Analysis of Patients with Parkinson''s Disease during Treadmill and Floor Walking
by: Hui-Ju Lin, et al.
Published: (2000)

Cytokine Profile in Plasma Extracellular Vesicles of Parkinson’s Disease and the Association with Cognitive Function
by: Lung Chan, et al.
Published: (2021-03-01)

The investigation of object concept in patients with Parkinson''s disease
by: Wei-Chi Lin, et al.
Published: (2009)

The plasma proteome and outcome in patients with heart failure
by: Thong, Cao Huy
Published: (2015)

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease
by: Chun-Wei Chang, et al.
Published: (2020-01-01)

Plasma DNA Mediate Autonomic Dysfunctions and White Matter Injuries in Patients with Parkinson’s Disease
by: Meng-Hsiang Chen, et al.
Published: (2017-01-01)